Correlation Between BriaCell Therapeutics and Heartbeam Warrant

Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Heartbeam Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Heartbeam Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BriaCell Therapeutics Corp and Heartbeam Warrant, you can compare the effects of market volatilities on BriaCell Therapeutics and Heartbeam Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Heartbeam Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Heartbeam Warrant.

Diversification Opportunities for BriaCell Therapeutics and Heartbeam Warrant

0.57

Correlation Coefficient

BriaCell Therapeutics  Heartbeam Warrant

Very weak diversification

The 3 months correlation between BriaCell and Heartbeam is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Heartbeam Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam Warrant and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Heartbeam Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam Warrant has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Heartbeam Warrant go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and Heartbeam Warrant

Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to generate 1.8 times more return on investment than Heartbeam Warrant. However, BriaCell Therapeutics is 1.8 times more volatile than Heartbeam Warrant. It trades about 0.12 of its potential returns per unit of risk. Heartbeam Warrant is currently generating about 0.16 per unit of risk. If you would invest  28.00  in BriaCell Therapeutics Corp on September 20, 2024 and sell it today you would earn a total of  5.00  from holding BriaCell Therapeutics Corp or generate 17.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

BriaCell Therapeutics Corp  vs.  Heartbeam Warrant

BriaCell Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Heartbeam Warrant

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Heartbeam Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BriaCell Therapeutics and Heartbeam Warrant

The main advantage of trading using opposite BriaCell Therapeutics and Heartbeam Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Heartbeam Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam Warrant will offset losses from the drop in Heartbeam Warrant's long position.

The idea behind BriaCell Therapeutics Corp and Heartbeam Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.